CAR-T International Medical Services

China International Medical Tourism Co., Ltd.

SERVICE PLATFORM

Integrated Diagnosis and Treatment Platform for International Patients in China

Whole Process Planning

  • First walk through illness and demand
  • Meeting and admission to the hospital
  • Security and immigration fraud
  • Employment itinerary
  • Follow-up to illness

Expert Consultation

  • sick collection collection
  • sick translation
  • Character meeting
  • Viewing session

Local Guide Services

  • Collaborative clinic contact box
  • Qingding Hotel Residence
  • Character meeting
  • Conveyance machine and transportation
  • Daily life assistance
  • Daily travel guide and assistance

Hospital Guide Service

  • Designated clinic network
  • Collaboration support and management, residential hospital reception management
  • Clinic translation
  • Collaboration development ticket installation

CAR-T Treatment

  • CART Cell Technology Service

Family Accommodation

  • 2 people/monthly calculation
  • Provided accommodation assistance for foreigners (foreigner public security machine planning registration, foreign capital quality hotel, public housing, residential housing selection)

Whole Process Planning

  • First walk through illness and demand
  • Meeting and admission to the hospital
  • Security and immigration fraud
  • Employment itinerary
  • Follow-up to illness

Expert Consultation

  • sick collection collection
  • sick translation
  • Character meeting
  • Viewing session

Local Guide Services

  • Collaborative clinic contact box
  • Qingding Hotel Residence
  • Character meeting
  • Conveyance machine and transportation
  • Daily life assistance
  • Daily travel guide and assistance

Hospital Guide Service

  • Designated clinic network
  • Collaboration support and management, residential hospital reception management
  • Clinic translation
  • Collaboration development ticket installation

CAR-T Treatment

  • CART Cell Technology Service

Family Accommodation

  • 2 people/monthly calculation
  • Provided accommodation assistance for foreigners (foreigner public security machine planning registration, foreign capital quality hotel, public housing, residential housing selection)

INTRODUCTION OF TREATMENT REGIMEN

(Equecabtagene Autoleucel Injection) The World’s First Approved Fully-human CAR-T

Approved Indications

Equecabtagene Autoleucel Injection is used to treat adult patients with recurrent or refractory multiple myeloma who have progressed after at least third-line therapy

Note: At least one proteasome inhibitor and one immunomodulatory agent have been used been used

  • The world’s first approved fully-human CAR-T Breakthrough fully-human CAR structure: low immunogenicity, long persistence
  • China's first approved CAR-T for the treatment of multiple myeloma
  • China's first independently researched and fully self-produced CAR-T

Equecabtagene Autoleucel Injection Has Excellent Clinical Efficacy

  • Strong tumoricidal

    ORR 98.9% ≥CR 82.4% MRD negative rate 97.8%

  • Long duration

    Median durability 419 days 12-month sustained MRD negative rate 80.8% 12-month PFS rate 85.5%

  • Excellent safety

    ≥ Grade 3 ICANS 0% Incidence of ≥ Grade 3 CRS only 1% No movement/cognitive impairment No Parkinson's disease

  • One infusion

    Single treatment, return to normal life

iaso-logo fucasu-logo

IASO Equecabtagene Autoleucel (BCMA CART) NDA approval

iaso

Data source:

  1. 2023 International Myeloma Society Annual Meeting (20th, IMS)
  2. FUMANBA-1 Clinical Study Data (CTR20192510, NCT05066646)

INTRODUCTION OF TREATMENT CENTERS

We Have a World-Class Medical Center Network Throughout China, Serving Global Patients.

IntroduIntroduction of Treatment Centerszction of Treatment Centers Learn more about the treatment center

INTRODUCTION OF SERVICE PACKAGE

Highlights of the Integrated Service Package for International CAR-T Therapy

CAR-T Therapy Package

Equity and Services

Service Star

Service Team

VIP Service Team

Medical Resources

TOP 10 Hematologic Oncology Hospitals in China

Medical Team

Chief Physicians of Hematology and Their Team

Translation Team

Outpatient + Inpatient + Daily Life (appointment 1 day in advance)

Hospital Admission Examination

International Outpatient Clinic

CAR-T

Equecabtagene Autoleucel Injection

Inpatient Standard

Superior Single Room

Accommodation Standard

Five-Star Hotel (30 Days)

Travel Standard

Business/Luxury Vehicle

During Treatment

VIP Lutong in the Whole Process (expedited on the same day)

Additional Services

Accident Insurance for 2 persons (insurance amount of 200,000)

Core Services Content of International CAR-T Therapy

TOP 10

HematologicOncology Hospitals in China

therapy

Consultation during Whole Process

Medical Consultant One-to-one Management during Whole Process

therapy

Expert Assessment

TOP 10 Hematologic Oncology Hospitals in China One-to-One Video Consultation with Chief physician

therapy 03

Hospitali sation

TOP 10 Hospitals Single Ward and Related Examinations

therapy 04
therapy

CAR-T Therapy

Equecabtagene Autoleucel Injection

At the 2023 International Myeloma Society (IMS) annual meeting, IASO presented two study results of the CAR-T product Equecabtagene Autoleucel Injection. The updated follow-up data showed that in terms of efficacy, the objective response rate (ORR) for subjects who had not previously received CAR-T therapy reached 98.9%, and the rate of stringent complete response/complete response (sCR/CR) increased to 82.4%.

05

Accommodation Standard

Hotel Standard

(Arrangement of Temporary Accommodation, and Registration with Public Security Organs for Overseas Personnel)

therapy

Travel Standard

Business/Luxury Vehicle

therapy
08

Additional Services

Accident Insurance (Insurance Amount of 200,000)

Guarantee Period

1 Year

Premium

235 Yuan (Premium Scheme)

Age

1-80 Years Old

Medical Deductibles

0 Yuan

Insurance Liability

Insurance Amount (Premium Scheme)

Accidental Death/Disability

200,000 (Maximum)

Compensationfor Medical Expenses

50,000

Compensationfor Medical Expenses of Disease During Domestic Travel

1000

Consolence and Visit Expenses

8000

HospitalizationAllowance

50/day,up to 90 days

24HGlobal Emergency Aid Service

100,000

IndividualResponsibilities During Travel

80,000

TOP 10

HematologicOncology Hospitals in China

therapy

Consultation during Whole Process

Medical Consultant One-to-one Management during Whole Process

therapy

Expert Assessment

TOP 10 Hematologic Oncology Hospitals in China One-to-One Video Consultation with Chief physician

therapy 03

Hospitali sation

TOP 10 Hospitals Single Ward and Related Examinations

therapy 04
therapy

CAR-T Therapy

Equecabtagene Autoleucel Injection

At the 2023 International Myeloma Society (IMS) annual meeting, IASO presented two study results of the CAR-T product Equecabtagene Autoleucel Injection. The updated follow-up data showed that in terms of efficacy, the objective response rate (ORR) for subjects who had not previously received CAR-T therapy reached 98.9%, and the rate of stringent complete response/complete response (sCR/CR) increased to 82.4%.

05

Accommodation Standard

Hotel Standard

(Arrangement of Temporary Accommodation, and Registration with Public Security Organs for Overseas Personnel)

therapy

Travel Standard

Business/Luxury Vehicle

therapy
08

Additional Services

Accident Insurance (Insurance Amount of 200,000)

Guarantee Period

1 Year

Premium

235 Yuan (Premium Scheme)

Age

1-80 Years Old

Medical Deductibles

0 Yuan

Insurance Liability

Insurance Amount (Premium Scheme)

Accidental Death/Disability

200,000 (Maximum)

Compensationfor Medical Expenses

50,000

Compensationfor Medical Expenses of Disease During Domestic Travel

1000

Consolence and Visit Expenses

8000

HospitalizationAllowance

50/day,up to 90 days

24HGlobal Emergency Aid Service

100,000

IndividualResponsibilities During Travel

80,000

Five-star Service Package of International CAR-T Therapy

Service Classification Service Category Services Equity
Appointment Services
Authoritative Hospitals and Expert Recommendations
MailingServices for Image FilmSlides
Appointment of Hospital andExpert
Appointment of PhysicalExamination for Accompany (Free) 1 Person
HospitalInvitation Letter
Hospital CostEstimation Letter
Assist in VisaProcessing
Travel Services
Assist in Booking Round-trip Flight Ticket
Guidance onOverseas Payment (Alipay Account Registration, Currency Exchange)
Two Pre-departureOnline Meetings (Contract Guidance + Pre-departureGuidance, including Translation)
Vehicle Standard Comfortable Car
Vehicle Service(Hospital-residence Round Trip) 10 Times
Pick-up or Drop-offServices at DomesticAirports
Translation Services
Accompanying and Translation Service in Hospital (Professional Medical Personnel) 6 Times ( < 4 h/time)
Accompanying and Translation Service in Daily Life 5 Times ( <4 h/time)
Translation Service in Daily Life (iFlytek Global Translator) Note: A deposit of 5000 yuan is required 1 Month
Medical Services
CAR-T Product Equecabtagene Autoleucel Injection
Basic Treatment Pre-treatment Evaluation and Related Examinations, T-cell Collection,
Hospitalization Lymphocyte-clearing Chemotherapy, CAR-T Reinfusion, Evaluation 6 Weeks (without ICU)
Local Services
Accommodation Arrangement (Foreign-related Hotels, registration with Public Security Bureau) Five-star Hotels for 30 days
Mobile Phone for Communication (with Social Software such as Whatsup, Facebook and Application Software such as Alipay, Translation Software) Note: A deposit of 5000 yuan is required 1 Month
Local SIM Card (Free Telephone Fee) RMB 300
Medical Document Translation Service (Discharge Summary in English)
Information Inquiry Report of Related Disease (Free)
Assist in Visa Extension
Assistance with Hospital Settlement and Refund Guidance
Assistance with Hotel Lease Termination Procedures
Assistance with Arranging Return Matters
Assistance with Mailing Hospital Bills

SERVICE PROCESS

Integrated diagnosis and treatment services for international patients in China

SERVICE PROCESS Learn more about the Car-T Treatment Process

ABOUT US

About Us

China International Medical Tourism Co., Ltd.

An institution that provides global customers with advanced medical technology services and solutions for medical fee payment

  • The company cooperates with hospitals in China, Japan, the United States, and other regions to assist patients with international travel and receiving medical services quipped with advanced technology.
  • As a global medical platform, the company integratesglobal oncologist and new drugs and technologies, helping thousands of patientswith tumors in China, the United States, and Japan to receive new drugs andtechnologies consultation and treatment every year, and also assists numerousinternational patients to go to China for anticancer therapies such as CAR-T,TILs, and cancer vaccines.

An antitumor assistant for patients with tumors

A medical platform for oncologist

A close partner of innovative antitumor drug manufacturers

Continue to fight cancers hand in hand with global patients, and conquer cancer as early as possible!

Jointly Creating an Integrated CAR-T Treatment Service Platform for International Patients

Providing Global Patients with High-quality CAR-T Treatment Experiences and Hopes for Cure

pic

Contact us immediately to resolve your issue via Email or phone.

INQUIRY NOW

×
Fucaso® (Equecabtagene Autoleucel Injection)

-- The World's First Approved Fully Human CAR-T Therapy

Breakthrough fully human CAR structure
  • Full epitope of light and heavy chains binds tightly to BCMA
  • Fast dissociation, low exhaustion
  • Low immunogenicity
Durable persistence
  • Median duration of persistence time 419 days
  • 12-month sustained MRD negativity rate 81.7%
  • 12-month PFS rate 85.5%
Strong efficacy
  • ORR 98.9%
  • ≥CR rate 82.4%
  • MRD negativity rate 97.8%
Returning to life upon single-dose treatment
Excellent safety
  • No ≥ Grade 3 ICANS
  • Incidence of ≥ Grade 3
  • No movement/cognitive disorder observed No Parkinson's disease found